Physician Wealth Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Physician Wealth Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9	Closed	-$423	–	2045
2025 Q2	$423	Buy	+9	New	+$400	﹤0.01%	1750

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Physician Wealth Advisors's SWTX Position: Q3 2025 in Review

Physician Wealth Advisors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 9 shares — an estimated $423 sold.

Physician Wealth Advisors first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $423 in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Physician Wealth Advisors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Physician Wealth Advisors sold 9 SpringWorks Therapeutics shares in Q3 2025, an estimated $423.
Physician Wealth Advisors first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Physician Wealth Advisors's SpringWorks Therapeutics position peaked at $423 in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Physician Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.